PHARMACY

Sainsbury houses UK’s first in-store supermarket clinic

BY Antoinette Alexander

LONDON J Sainsbury has become the first supermarket in the country to offer an in-store physician-staffed clinic.

According to published reports, the initiative, dubbed Doctors in Store, is the idea of Manchester-area family physician Mohammed Jiva.

The clinic, located inside the pharmacy area of Sainbury’s store in Heaton Park, is the first phase of a six-month pilot by Heywood, Middleton and Rochdale Primary Care Trust. Two more clinics are likely to open later this year, possibly in Rochdale town centre, according to reports.

The in-store clinic is not meant to replace a patient’s traditional doctor but to provide extended hours medical care. The Doctors in Store physicians will be able to access patients’ medical records online and refer patients on for more treatment, as well as prescribe medication and update their notes, reports stated.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Rx program more expensive than chain store prescriptions

BY Diana Alickaj

DENVER Rx Outreach, a Colorado program aimed at helping low-income people afford drugs for chronic diseases, was found to be more expensive for purchasing drugs than regular chain-store pharmacies.

A 90-day supply from a choice of 110 generics costs about $20 each, and three-dozen other drugs sell for $30 and $40. In contrast, Kmart’s program for a choice of 300 generic medications for a 90-day supply retails for $15, while Costco sells their prescriptions for about $10.66 and Walgreens sells them for about $12.99.

The program, Colorado Cares Rx, was unveiled this month by the Department of Health Care Policy and financing in partnership with Rx Outreach. The program was started by the state to develop a low-cost drug program, but the sponsors are finding it harder to compete with chain store rivals, based on pricing.

Officials claim growing pains, however. Rep. Alice Madden, D-Boulder, said “This is just a first step. We have to do more.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

FDA approves Abilify for teens

BY Drew Buono

TOKYO and PRINCETON, N.J. The Food and Drug Administration has approved the Otsuka Pharmaceuticals and Bristol-Myers Squibb drug application for Abilify for the acute treatment of manic and mixed episodes associated with bipolar I disorder, with or without psychotic features in pediatric patients aged 10 to 17.

The approval is based on the results of a four-week study that compared Abilify to a placebo in treating pediatric patients with bipolar disorder I. Otsuka Pharmaceuticals sponsored the study.

“We are pleased that the FDA has approved Abilify to treat pediatric patients aged 10 to 17 years suffering from Bipolar I Disorder,” said Taro Iwamoto, Ph.D., chief executive officer, president and chief operating officer, Otsuka Pharmaceutical development and c commercialization. “The approval of this new indication for ABILIFY provides clinicians with expanded treatment options that can help address the therapeutic needs of this population.” 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES